Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC

Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post by ASCO on X and added:

“Just in ASCO Daily News where Nazli Dizman, Emre Yekedüz, and I briefly discuss immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC, under the mentorship of Toni Choueiri!”

Quoting ASCO‘s post:

“For ASCO Daily News, Toni Choueiri, Nazli Dizman, Marc Machaalani, and Emre Yekedüz examine recent/ongoing research efforts exploring IO rechallenge after prior ICI exposure to understand its potential in mRCC.”

Source: Marc Machaalani/X and ASCO/X